From a physiopathological perspective, inflammation inhibits insulin action through the release of cytokines and adipocytokines and contributes to the progression from insulin resistance to the development of hyperglycemia [26], which explain the higher rates of dysglycemia and diabetes in the group with metabolic syndrome. The gene discussed is INS; the disease is Insulin resistance.